Despite trastuzumab being a game-changing treatment for HER2-positive breast cancers over the past two decades, its success has come with key gaps in the understanding of how, exactly, it works.
Read More
Despite trastuzumab being a game-changing treatment for HER2-positive breast cancers over the past two decades, its success has come with key gaps in the understanding of how, exactly, it works.
Read More